Description
Tramadol Retard Zentiva 150 mg is a prolonged-release formulation of tramadol hydrochloride, a centrally acting analgesic used for the treatment of moderate to severe pain. The “retard” in the name indicates that it is a sustained-release formulation designed to release the tablet gradually over time, providing longer-lasting pain relief.
Key Information
- Active Ingredient: Tramadol hydrochloride
- Strength: 150 mg per tablet
- Formulation: Prolonged-release tablet
- Brand: Zentiva
Indications
Tramadol Retard Zentiva 150 mg is indicated for the management of moderate to severe pain in adults that requires continuous, around-the-clock treatment for an extended period.
Mechanism of Action
Tramadol works by binding to the mu-opioid receptors in the brain and inhibiting the reuptake of norepinephrine and serotonin, which modulates the perception of pain.
Dosage and Administration
- Initial Dose: The typical starting dose for adults is one 150 mg prolonged-release tablet taken once daily.
- Titration: The dose may be adjusted based on the patient’s response and pain severity. It is important to follow the prescribing doctor’s instructions.
- Administration: Tablets should be swallowed whole with water and should not be split, crushed, or chewed to maintain the prolonged-release properties.
Contraindications
- Hypersensitivity: Patients with known hypersensitivity to tramadol or any other components of the formulation.
- Acute Intoxication: Patients with acute intoxication with alcohol, hypnotics, centrally acting analgesics, opioids, or psychotropic tablet .
- Respiratory Depression: Patients with severe respiratory depression.
- Monoamine Oxidase Inhibitors (MAOIs): Concomitant use with MAOIs or within 14 days of discontinuing them.
Reviews
There are no reviews yet.